(Q39479797)

12 September 2017

title

A chimeric measles virus with a lentiviral envelope replicates exclusively in CD4+/CCR5+ cells (English)

1 reference

12 September 2017

1 reference

6

Frédéric Tangy

1 reference

12 September 2017

3

Chantal Combredet

1 reference

12 September 2017

4

Valérie Najburg

1 reference

12 September 2017

5

Nadège Cayet

1 reference

12 September 2017

Thomas Mourez

1

1 reference

12 September 2017

Mariana Mesel-Lemoine

series ordinal

2

1 reference

12 September 2017

language of work or name

English

0 references

publication date

3 September 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

419

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

117-125

1 reference

The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

The Pathogenesis of Measles Revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Measles virus receptors: SLAM and CD46.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Early target cells of measles virus after aerosol infection of non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Progress and obstacles in the development of an AIDS vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

A call for replicating vector prime-protein boost strategies in HIV vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

The role of antibodies in HIV vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Transmission, acute HIV-1 infection and the quest for strategies to prevent infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

A chimeric measles virus with canine distemper envelope protects ferrets from lethal distemper challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

SLAM (CDw150) is a cellular receptor for measles virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Measles virus replication in lymphatic cells and organs of CD150 (SLAM) transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Measles virus: cellular receptors, tropism and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Chimeric measles viruses with a foreign envelope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.08.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2011.08.007

1 reference

12 September 2017

1 reference